On the first day of the implementation of the filing system for pharmaceutical representatives, 7 acts were strictly prohibited

Medical Network December 2nd, December 1st, "Pharmaceutical Representative Filing Management Measures (Trial)" officially implemented.
, the pharmaceutical representative refers to a professional who, on behalf of the licensed holder of the drug, is engaged in the transmission, communication and feedback of the drug within the territory of the People's Republic of China.
medical representatives may communicate with medical personnel and pharmaceutical personnel in person at medical institutions, hold academic conferences, lectures, provide academic materials, communicate through the Internet or teleconses, and carry out academic promotion activities in other forms agreed by medical institutions.
Its main tasks include the following four tasks: (1) formulating plans and programs for the promotion of pharmaceutical products; (2) transmitting relevant information on pharmaceutical products to medical personnel; (3) assisting medical personnel in the rational use of pharmaceutical products of the enterprise; and (4) collecting and feedback on the clinical use of pharmaceutical products and hospital needs.
Drug listing license holders shall submit the following filing information on the filing platform: (1) the name of the drug listing license holder, the unified social credit code; (2) the name, gender and photograph of the pharmaceutical representative; (3) the type and number of identity documents, the major and education studied; (4) the start and end dates of labor contracts or authorizations; (5) the types of drugs and therapeutic fields that the pharmaceutical representative is responsible for promoting; (6) the statement of the drug listing license holder on the authenticity of the information for the record; and after the filing information is submitted, the filing platform automatically generates the pharmaceutical representative's filing number.
The measures for filing and administration require that pharmaceutical representatives shall not have the following circumstances: (1) carrying out academic promotion and other activities without the record; (2) carrying out academic promotion activities without the consent of medical institutions; (3) taking on the task of drug sales, carrying out sales activities such as collecting and handling purchase and sale bills; and (4) participating in the issuance of individual statistical doctors the number of prescriptions for drugs; (5) providing donations, grants and sponsorships directly to departments and individuals in medical institutions; (6) misleading doctors about the use of drugs, exaggerating or misleading the efficacy, concealing information about known adverse reactions to drugs or concealing information on adverse reactions to doctor feedback; and (7) other interventions or acts affecting clinically reasonable drug use.
For pharmaceutical representatives who have the above-mentioned situations, the drug market license holder shall promptly correct them, and if the circumstances are serious, they shall suspend the authorization to carry out academic promotion and other activities, and train them in posts, and reconfirm the authorization after passing the examination.
。